TrialBreast cancer research and treatment2026

Prognostic and predictive performance of PREDICT 2.1, PREDICT v3, and RSClin in node-negative early breast cancer: a TEAM pathology substudy.

Andréanne Leblanc et al.PubMed ↗Publisher ↗

No numbers read from the abstract.